CAMP
CAMP4 THERAPEUTICS CORPORATION
3.80$
+3.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 45.7% | 72.8% | 49.4% | 49.4% | 25.8% | 84.8% | 82.3% | 80.1% | 89.9% | 96.8% | 96.9% | 96.4% | |
| 10.6% | 69.9% | 42.1% | 42.1% | 11.8% | 81.8% | 78.6% | 76.2% | 87.1% | 93.0% | 94.1% | 93.3% | |
| 10.6% | 69.9% | 42.1% | 42.1% | 11.8% | 81.8% | 78.6% | 76.2% | 87.1% | 93.0% | 94.1% | 93.3% | |
| 19.6% | 0.8% | – | 1.2% | 5.2% | 0.1% | 0.2% | 0.2% | 0.1% | 0.1% | – | 0.2% | |
| 8.2% | 62.0% | – | – | – | – | – | – | – | – | – | – | |
| 26.2% | 37.5% | – | – | – | – | – | – | – | – | – | – | |
| 6.8% | 43.0% | – | – | – | – | – | – | – | – | – | – | |
| 97.1% | 325.2% | 49.8% | 591.3% | 844.1% | 19.4% | 17.8% | 22.0% | 32.1% | 59.5% | 70.7% | 100.7% | |
| 26.3% | 14.2% | 26.0% | 26.0% | 55.4% | 12.3% | 10.3% | 14.3% | 9.1% | 13.2% | 15.8% | 20.5% | |
| 1.3% | 8.7% | 11.3% | 10.4% | 14.5% | 3.9% | 5.0% | 6.2% | 3.8% | 0.2% | 0.4% | 0.9% | |
| 12.7% | 85.0% | 4.9% | 4.9% | 18.1% | 1.5% | 2.2% | 2.3% | 1.4% | 0.2% | 0.8% | 1.2% | |
| 2.9% | -225.2% | 50.2% | -491.3% | -744.1% | 80.6% | 82.2% | 78.0% | 67.9% | 40.5% | 29.3% | -0.7% | |
| -48.7% | -291.1% | -617.8% | -617.8% | -929.0% | -270.4% | -357.1% | -461.8% | -291.5% | -248.0% | -294.4% | -368.2% | |
| 10.2% | 35.5% | 40.5% | 65.1% | 91.3% | 24.9% | 31.1% | 39.3% | 23.3% | 44.1% | 54.9% | 62.0% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.